Xintian Pharma
0028737.682.54% ( +0.19 )
Xintian Pharma (002873)
Guiyang Xintian Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of new traditional Chinese m...
- Open
- 7.51
- High
- 7.68
- Low
- 7.50
- Prev. Close
- 7.49
- Volume
- 62.83K
- Turnover
- 47.90M
- Avg Price
- 7.62
- Bid/Ask Ratio
- -47.10%
- Amplitude
- 2.40%
- 52wk High
- 15.16
- Volume Ratio
- 0.56
- Turnover Ratio
- 2.57%
Xintian Pharma Analyst Rating
View MoreForecast & Rating
Apr 18, 2024Price forecast
¥16.68117.19%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Oct 30, 2025 at 03:43 AM
Xintian Pharma released its performance for the first three quarters, with a net profit attributable to the parent company of 16.1809 million yuan, a year-on-year decrease of 73.47%
- Zhitong · Oct 20, 2025 at 09:02 AM
Xintian Pharma's controlling shareholder, Xintian Zhiyao, plans to reduce its holdings by no more than 7.05 million shares
- Zhitong · Oct 14, 2025 at 03:37 AM
Xintian Pharma: Xinlikang capsules approved to conduct clinical trials for the treatment of cancer-related fatigue
- Zhitong · Sep 4, 2025 at 04:11 AM
Xintian Pharma establishes a new company in traditional Chinese medicine health technology
- Zhitong · Sep 3, 2025 at 04:48 AM
Xintian Pharma: Subsidiary Zhongdao Health registered capital of 10 million yuan
- Zhitong · Sep 3, 2025 at 03:35 AM
Xintian Pharma's subsidiary has obtained an invention patent for the "Ginkgo Biloba Water Decoction Fingerprint Map"
